Vaccine infographic7/5/2023 ![]() They also wanted to see if the three-stage regimen they were testing would create the desired immune responses. Researchers mostly set out to see whether the therapy would be safe and even feasible. ![]() The study wasn’t designed to test whether the vaccines would be effective. “It remains to be seen, but certainly very exciting preliminary results,” she said. Neeha Zaidi, an oncologist at Johns Hopkins Kimmel Cancer Center who was not involved in the new research. It highlights the mRNA platform and the versatility to be able to personalize or tailor these vaccines to each patient’s specific tumor and generate these customized vaccines in a fairly short amount of time,” said Dr. Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation In blood tests, all eight responders made T-cells against their tumors, and those have persisted for at least two years despite a followup course of chemotherapy.Īmong the eight patients who did not respond adequately to the vaccine, just two have not seen their cancer return.Ī cancer patient holds the IV tubes during chemotherapy. None of those eight has seen their cancer return. Of the 16 patients who were able to complete all phases of the study, eight responded to the vaccine, which taught their immune systems how to recognize and fight off the cancer cells. ![]() The results of the study were published Wednesday in the journal Nature. She credits an experimental therapy – a personalized cancer vaccine – being tested by BioNTech, one of the companies that helped make the mRNA vaccines for Covid-19.īrigham was one of 16 participants in a recent test of the new technology. Today, nearly three years after her diagnosis, Brigham says regular scans find no trace of cancer in her pancreas. ![]()
0 Comments
Leave a Reply. |